News Releases

Month Year

Month Year

Jul 8, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jun 3, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 23, 2022

Insmed Names Drayton Wise Chief Commercial Officer
May 17, 2022

Insmed Presents New Data Across Three Pillars at American Thoracic Society 2022 International Conference
May 17, 2022

Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference
May 6, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 5, 2022

Insmed Reports First Quarter 2022 Financial Results and Provides Business Update
Apr 21, 2022

Insmed to Host First Quarter 2022 Financial Results Conference Call on Thursday, May 5, 2022
Apr 7, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Mar 28, 2022

Insmed to Showcase New Data Across Three Pillars at the American Thoracic Society 2022 International Conference

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation